This inventor holds 1 USPTO granted patent. Top assignee: Karyopharm Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sean Howard Wiedemann: Innovator in Pharmaceutical Development
Introduction
Sean Howard Wiedemann is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on innovative drug formulations. His expertise and dedication have led to advancements that benefit the medical community and patients alike.
Latest Patents
Sean Howard Wiedemann holds a patent for the "Crystalline Form of Selinexor." This invention represents a crucial development in the treatment of various cancers, showcasing his commitment to improving therapeutic options.
Career Highlights
Wiedemann is currently employed at Karyopharm Therapeutics Inc., a company known for its focus on developing novel cancer therapies. His role at Karyopharm has allowed him to contribute to groundbreaking research and development efforts in the pharmaceutical industry.
Collaborations
Throughout his career, Sean has collaborated with talented professionals, including Bojan Dragisic and Stephen Edmund Gottschling. These partnerships have fostered an environment of innovation and creativity, leading to successful outcomes in their projects.
Conclusion
Sean Howard Wiedemann is a distinguished inventor whose work in pharmaceuticals has made a significant impact. His contributions, particularly in the development of the crystalline form of Selinexor, highlight his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile